GSK3B and neoplasm: Similarly, the inhibition of GSK-3β in glioblastoma (GBM)-specific IL13 chimeric antigen receptor expressing T (IL13-CAR-T) cells increased the survival and proliferation of CAR-positive T cells upon activation with IL13Rα2-expressing GBM tumor cells, or soluble target antigen.